Levels of carcinoembryonic antigen (CEA), the current biomarker used to monitor CRC patients, were normal both before and after surgery, and only rised at 6 months after ctDNA was found positive (Figure 6D). This evidence concerns the gene CEACAM5 and colorectal carcinoma.